nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR7—Parkinson's disease	0.122	0.163	CbGaD
Amoxapine—DRD3—Parkinson's disease	0.115	0.154	CbGaD
Amoxapine—DRD1—Parkinson's disease	0.113	0.151	CbGaD
Amoxapine—SLC6A3—Parkinson's disease	0.107	0.143	CbGaD
Amoxapine—HTR1A—Parkinson's disease	0.0936	0.125	CbGaD
Amoxapine—DRD2—Parkinson's disease	0.0794	0.106	CbGaD
Amoxapine—HTR2A—Parkinson's disease	0.0614	0.0822	CbGaD
Amoxapine—CYP2D6—Parkinson's disease	0.0561	0.0752	CbGaD
Amoxapine—HTR3A—enteric nervous system—Parkinson's disease	0.00573	0.0544	CbGeAlD
Amoxapine—HTR3A—myenteric nerve plexus—Parkinson's disease	0.00434	0.0412	CbGeAlD
Amoxapine—HTR7—enteric nervous system—Parkinson's disease	0.00371	0.0352	CbGeAlD
Amoxapine—HTR7—superior cervical ganglion—Parkinson's disease	0.00355	0.0337	CbGeAlD
Amoxapine—HTR7—myenteric nerve plexus—Parkinson's disease	0.00281	0.0267	CbGeAlD
Amoxapine—DRD3—telencephalic ventricle—Parkinson's disease	0.00259	0.0246	CbGeAlD
Amoxapine—SLC6A2—locus ceruleus—Parkinson's disease	0.00254	0.0241	CbGeAlD
Amoxapine—HTR7—locus ceruleus—Parkinson's disease	0.00245	0.0232	CbGeAlD
Amoxapine—HTR2A—enteric nervous system—Parkinson's disease	0.00231	0.0219	CbGeAlD
Amoxapine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00201	0.0191	CbGeAlD
Amoxapine—HTR7—sympathetic nervous system—Parkinson's disease	0.00194	0.0184	CbGeAlD
Amoxapine—DRD1—telencephalic ventricle—Parkinson's disease	0.00186	0.0176	CbGeAlD
Amoxapine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00175	0.0166	CbGeAlD
Amoxapine—HTR2A—locus ceruleus—Parkinson's disease	0.00153	0.0145	CbGeAlD
Amoxapine—HTR1B—telencephalic ventricle—Parkinson's disease	0.00151	0.0143	CbGeAlD
Amoxapine—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00149	0.0142	CbGeAlD
Amoxapine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00144	0.0137	CbGeAlD
Amoxapine—HTR7—pons—Parkinson's disease	0.00141	0.0134	CbGeAlD
Amoxapine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00135	0.0128	CbGeAlD
Amoxapine—HTR7—autonomic nervous system—Parkinson's disease	0.0013	0.0123	CbGeAlD
Amoxapine—HTR2A—cerebellar cortex—Parkinson's disease	0.00124	0.0118	CbGeAlD
Amoxapine—HTR1A—telencephalic ventricle—Parkinson's disease	0.00121	0.0115	CbGeAlD
Amoxapine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00121	0.0115	CbGeAlD
Amoxapine—DRD1—nerve—Parkinson's disease	0.00117	0.0111	CbGeAlD
Amoxapine—HTR7—telencephalic ventricle—Parkinson's disease	0.00116	0.011	CbGeAlD
Amoxapine—HTR3A—nerve—Parkinson's disease	0.00113	0.0107	CbGeAlD
Amoxapine—DRD2—telencephalic ventricle—Parkinson's disease	0.0011	0.0104	CbGeAlD
Amoxapine—SLC6A3—nerve—Parkinson's disease	0.000941	0.00893	CbGeAlD
Amoxapine—HTR7—peripheral nervous system—Parkinson's disease	0.000939	0.00891	CbGeAlD
Amoxapine—HTR2A—pons—Parkinson's disease	0.00088	0.00835	CbGeAlD
Amoxapine—HTR2A—autonomic nervous system—Parkinson's disease	0.000811	0.0077	CbGeAlD
Amoxapine—SLC6A2—nerve—Parkinson's disease	0.000759	0.0072	CbGeAlD
Amoxapine—HTR7—nerve—Parkinson's disease	0.000732	0.00694	CbGeAlD
Amoxapine—HTR2A—telencephalic ventricle—Parkinson's disease	0.000724	0.00687	CbGeAlD
Amoxapine—GABRA1—hindbrain—Parkinson's disease	0.000711	0.00674	CbGeAlD
Amoxapine—SLC6A3—hindbrain—Parkinson's disease	0.000705	0.00669	CbGeAlD
Amoxapine—DRD2—nerve—Parkinson's disease	0.000692	0.00656	CbGeAlD
Amoxapine—ADRA2A—peripheral nervous system—Parkinson's disease	0.000688	0.00653	CbGeAlD
Amoxapine—HTR6—forebrain—Parkinson's disease	0.000652	0.00619	CbGeAlD
Amoxapine—SLC6A4—hindbrain—Parkinson's disease	0.000646	0.00613	CbGeAlD
Amoxapine—HTR2A—peripheral nervous system—Parkinson's disease	0.000585	0.00555	CbGeAlD
Amoxapine—HTR1A—hindbrain—Parkinson's disease	0.000574	0.00544	CbGeAlD
Amoxapine—HTR7—hindbrain—Parkinson's disease	0.000548	0.0052	CbGeAlD
Amoxapine—ADRA1A—hindbrain—Parkinson's disease	0.000529	0.00502	CbGeAlD
Amoxapine—DRD2—hindbrain—Parkinson's disease	0.000518	0.00492	CbGeAlD
Amoxapine—DRD1—brainstem—Parkinson's disease	0.000503	0.00477	CbGeAlD
Amoxapine—HTR3A—brainstem—Parkinson's disease	0.000486	0.00461	CbGeAlD
Amoxapine—DRD1—forebrain—Parkinson's disease	0.000485	0.0046	CbGeAlD
Amoxapine—HTR3A—forebrain—Parkinson's disease	0.000469	0.00445	CbGeAlD
Amoxapine—HTR2A—nerve—Parkinson's disease	0.000456	0.00433	CbGeAlD
Amoxapine—HTR1B—brainstem—Parkinson's disease	0.000407	0.00386	CbGeAlD
Amoxapine—GABRA1—brainstem—Parkinson's disease	0.000407	0.00386	CbGeAlD
Amoxapine—SLC6A3—brainstem—Parkinson's disease	0.000404	0.00383	CbGeAlD
Amoxapine—DRD4—brain—Parkinson's disease	0.0004	0.0038	CbGeAlD
Amoxapine—HTR1B—forebrain—Parkinson's disease	0.000393	0.00373	CbGeAlD
Amoxapine—GABRA1—forebrain—Parkinson's disease	0.000393	0.00373	CbGeAlD
Amoxapine—HTR2C—brainstem—Parkinson's disease	0.000391	0.00371	CbGeAlD
Amoxapine—SLC6A3—forebrain—Parkinson's disease	0.00039	0.0037	CbGeAlD
Amoxapine—DRD3—head—Parkinson's disease	0.000388	0.00368	CbGeAlD
Amoxapine—HTR2C—forebrain—Parkinson's disease	0.000377	0.00358	CbGeAlD
Amoxapine—HTR6—head—Parkinson's disease	0.000373	0.00354	CbGeAlD
Amoxapine—SLC6A4—brainstem—Parkinson's disease	0.00037	0.00351	CbGeAlD
Amoxapine—DRD3—nervous system—Parkinson's disease	0.000368	0.00349	CbGeAlD
Amoxapine—SLC6A4—forebrain—Parkinson's disease	0.000357	0.00339	CbGeAlD
Amoxapine—CHRM1—forebrain—Parkinson's disease	0.000356	0.00338	CbGeAlD
Amoxapine—DRD3—central nervous system—Parkinson's disease	0.000354	0.00336	CbGeAlD
Amoxapine—HTR6—nervous system—Parkinson's disease	0.000354	0.00336	CbGeAlD
Amoxapine—HTR2B—forebrain—Parkinson's disease	0.000354	0.00336	CbGeAlD
Amoxapine—HTR2A—hindbrain—Parkinson's disease	0.000342	0.00324	CbGeAlD
Amoxapine—HTR6—central nervous system—Parkinson's disease	0.000341	0.00323	CbGeAlD
Amoxapine—HTR1B—cardiovascular system—Parkinson's disease	0.000332	0.00315	CbGeAlD
Amoxapine—Asenapine—HTR7—Parkinson's disease	0.000331	0.0553	CrCbGaD
Amoxapine—HTR1A—brainstem—Parkinson's disease	0.000329	0.00312	CbGeAlD
Amoxapine—SLC6A2—brainstem—Parkinson's disease	0.000326	0.00309	CbGeAlD
Amoxapine—DRD1—midbrain—Parkinson's disease	0.00032	0.00304	CbGeAlD
Amoxapine—HTR1A—forebrain—Parkinson's disease	0.000317	0.00301	CbGeAlD
Amoxapine—SLC6A2—forebrain—Parkinson's disease	0.000315	0.00298	CbGeAlD
Amoxapine—HTR7—brainstem—Parkinson's disease	0.000314	0.00298	CbGeAlD
Amoxapine—CYP2D6—hindbrain—Parkinson's disease	0.000311	0.00295	CbGeAlD
Amoxapine—Asenapine—DRD3—Parkinson's disease	0.000311	0.052	CrCbGaD
Amoxapine—Asenapine—DRD1—Parkinson's disease	0.000305	0.0511	CrCbGaD
Amoxapine—HTR7—forebrain—Parkinson's disease	0.000303	0.00288	CbGeAlD
Amoxapine—ADRA1A—brainstem—Parkinson's disease	0.000303	0.00288	CbGeAlD
Amoxapine—CHRM1—cardiovascular system—Parkinson's disease	0.000301	0.00286	CbGeAlD
Amoxapine—HTR2B—cardiovascular system—Parkinson's disease	0.000299	0.00284	CbGeAlD
Amoxapine—DRD2—brainstem—Parkinson's disease	0.000297	0.00282	CbGeAlD
Amoxapine—ADRA1A—forebrain—Parkinson's disease	0.000292	0.00277	CbGeAlD
Amoxapine—DRD2—forebrain—Parkinson's disease	0.000287	0.00272	CbGeAlD
Amoxapine—GABRA1—medulla oblongata—Parkinson's disease	0.000284	0.0027	CbGeAlD
Amoxapine—DRD3—brain—Parkinson's disease	0.000281	0.00267	CbGeAlD
Amoxapine—DRD1—head—Parkinson's disease	0.000278	0.00264	CbGeAlD
Amoxapine—Mazindol—SLC6A3—Parkinson's disease	0.000277	0.0464	CrCbGaD
Amoxapine—HTR2C—medulla oblongata—Parkinson's disease	0.000272	0.00258	CbGeAlD
Amoxapine—HTR6—brain—Parkinson's disease	0.000271	0.00257	CbGeAlD
Amoxapine—ORM1—spinal cord—Parkinson's disease	0.00027	0.00256	CbGeAlD
Amoxapine—HTR3A—head—Parkinson's disease	0.000268	0.00255	CbGeAlD
Amoxapine—HTR1A—cardiovascular system—Parkinson's disease	0.000268	0.00255	CbGeAlD
Amoxapine—DRD1—nervous system—Parkinson's disease	0.000263	0.0025	CbGeAlD
Amoxapine—GABRA1—midbrain—Parkinson's disease	0.00026	0.00246	CbGeAlD
Amoxapine—HTR1B—midbrain—Parkinson's disease	0.00026	0.00246	CbGeAlD
Amoxapine—SLC6A3—midbrain—Parkinson's disease	0.000257	0.00244	CbGeAlD
Amoxapine—HTR7—cardiovascular system—Parkinson's disease	0.000256	0.00243	CbGeAlD
Amoxapine—HTR3A—nervous system—Parkinson's disease	0.000254	0.00241	CbGeAlD
Amoxapine—DRD1—central nervous system—Parkinson's disease	0.000254	0.00241	CbGeAlD
Amoxapine—Asenapine—HTR1A—Parkinson's disease	0.000253	0.0424	CrCbGaD
Amoxapine—HTR1B—spinal cord—Parkinson's disease	0.000253	0.0024	CbGeAlD
Amoxapine—GABRA1—spinal cord—Parkinson's disease	0.000253	0.0024	CbGeAlD
Amoxapine—SLC6A3—spinal cord—Parkinson's disease	0.000251	0.00238	CbGeAlD
Amoxapine—HTR2C—midbrain—Parkinson's disease	0.000249	0.00236	CbGeAlD
Amoxapine—ADRA1A—cardiovascular system—Parkinson's disease	0.000247	0.00235	CbGeAlD
Amoxapine—HTR3A—central nervous system—Parkinson's disease	0.000245	0.00232	CbGeAlD
Amoxapine—HTR2C—spinal cord—Parkinson's disease	0.000243	0.0023	CbGeAlD
Amoxapine—Desloratadine—CYP2D6—Parkinson's disease	0.000236	0.0395	CrCbGaD
Amoxapine—SLC6A4—midbrain—Parkinson's disease	0.000236	0.00224	CbGeAlD
Amoxapine—SLC6A4—spinal cord—Parkinson's disease	0.00023	0.00218	CbGeAlD
Amoxapine—ORM1—nervous system—Parkinson's disease	0.000228	0.00216	CbGeAlD
Amoxapine—SLC6A2—medulla oblongata—Parkinson's disease	0.000227	0.00216	CbGeAlD
Amoxapine—HRH1—forebrain—Parkinson's disease	0.000226	0.00215	CbGeAlD
Amoxapine—HTR1B—head—Parkinson's disease	0.000225	0.00214	CbGeAlD
Amoxapine—GABRA1—head—Parkinson's disease	0.000225	0.00214	CbGeAlD
Amoxapine—SLC6A3—head—Parkinson's disease	0.000223	0.00212	CbGeAlD
Amoxapine—ADRA2A—forebrain—Parkinson's disease	0.000222	0.00211	CbGeAlD
Amoxapine—ORM1—central nervous system—Parkinson's disease	0.000219	0.00208	CbGeAlD
Amoxapine—HTR7—medulla oblongata—Parkinson's disease	0.000219	0.00208	CbGeAlD
Amoxapine—HTR2C—head—Parkinson's disease	0.000216	0.00205	CbGeAlD
Amoxapine—Asenapine—DRD2—Parkinson's disease	0.000215	0.036	CrCbGaD
Amoxapine—HTR2A—embryo—Parkinson's disease	0.000214	0.00203	CbGeAlD
Amoxapine—HTR1B—nervous system—Parkinson's disease	0.000213	0.00202	CbGeAlD
Amoxapine—GABRA1—nervous system—Parkinson's disease	0.000213	0.00202	CbGeAlD
Amoxapine—SLC6A3—nervous system—Parkinson's disease	0.000212	0.00201	CbGeAlD
Amoxapine—HTR1A—midbrain—Parkinson's disease	0.000209	0.00199	CbGeAlD
Amoxapine—HTR1B—central nervous system—Parkinson's disease	0.000205	0.00195	CbGeAlD
Amoxapine—GABRA1—central nervous system—Parkinson's disease	0.000205	0.00195	CbGeAlD
Amoxapine—HTR2C—nervous system—Parkinson's disease	0.000205	0.00194	CbGeAlD
Amoxapine—SLC6A4—head—Parkinson's disease	0.000205	0.00194	CbGeAlD
Amoxapine—HTR1A—spinal cord—Parkinson's disease	0.000204	0.00194	CbGeAlD
Amoxapine—CHRM1—head—Parkinson's disease	0.000204	0.00193	CbGeAlD
Amoxapine—SLC6A3—central nervous system—Parkinson's disease	0.000204	0.00193	CbGeAlD
Amoxapine—HTR2B—head—Parkinson's disease	0.000203	0.00192	CbGeAlD
Amoxapine—DRD1—brain—Parkinson's disease	0.000201	0.00191	CbGeAlD
Amoxapine—GABRA1—cerebellum—Parkinson's disease	0.000201	0.00191	CbGeAlD
Amoxapine—HTR7—midbrain—Parkinson's disease	0.0002	0.0019	CbGeAlD
Amoxapine—SLC6A3—cerebellum—Parkinson's disease	0.000199	0.00189	CbGeAlD
Amoxapine—HTR2C—central nervous system—Parkinson's disease	0.000197	0.00187	CbGeAlD
Amoxapine—HTR2A—brainstem—Parkinson's disease	0.000196	0.00186	CbGeAlD
Amoxapine—HTR7—spinal cord—Parkinson's disease	0.000195	0.00185	CbGeAlD
Amoxapine—HTR3A—brain—Parkinson's disease	0.000194	0.00184	CbGeAlD
Amoxapine—SLC6A4—nervous system—Parkinson's disease	0.000194	0.00184	CbGeAlD
Amoxapine—CHRM1—nervous system—Parkinson's disease	0.000193	0.00183	CbGeAlD
Amoxapine—HTR2B—nervous system—Parkinson's disease	0.000192	0.00182	CbGeAlD
Amoxapine—DRD2—midbrain—Parkinson's disease	0.000189	0.0018	CbGeAlD
Amoxapine—HTR2A—forebrain—Parkinson's disease	0.000189	0.00179	CbGeAlD
Amoxapine—SLC6A4—central nervous system—Parkinson's disease	0.000187	0.00177	CbGeAlD
Amoxapine—CHRM1—central nervous system—Parkinson's disease	0.000186	0.00177	CbGeAlD
Amoxapine—HTR2B—central nervous system—Parkinson's disease	0.000185	0.00176	CbGeAlD
Amoxapine—Olanzapine—HTR7—Parkinson's disease	0.000184	0.0308	CrCbGaD
Amoxapine—HTR1A—head—Parkinson's disease	0.000182	0.00172	CbGeAlD
Amoxapine—SLC6A2—head—Parkinson's disease	0.00018	0.00171	CbGeAlD
Amoxapine—CYP2D6—brainstem—Parkinson's disease	0.000178	0.00169	CbGeAlD
Amoxapine—Zuclopenthixol—DRD1—Parkinson's disease	0.000178	0.0298	CrCbGaD
Amoxapine—HTR7—head—Parkinson's disease	0.000174	0.00165	CbGeAlD
Amoxapine—Olanzapine—DRD3—Parkinson's disease	0.000173	0.0289	CrCbGaD
Amoxapine—CYP2D6—forebrain—Parkinson's disease	0.000172	0.00163	CbGeAlD
Amoxapine—HTR1A—nervous system—Parkinson's disease	0.000172	0.00163	CbGeAlD
Amoxapine—SLC6A2—nervous system—Parkinson's disease	0.000171	0.00162	CbGeAlD
Amoxapine—Olanzapine—DRD1—Parkinson's disease	0.00017	0.0284	CrCbGaD
Amoxapine—Desloratadine—ABCB1—Parkinson's disease	0.000169	0.0282	CrCbGaD
Amoxapine—ADRA1A—head—Parkinson's disease	0.000167	0.00159	CbGeAlD
Amoxapine—Asenapine—HTR2A—Parkinson's disease	0.000166	0.0278	CrCbGaD
Amoxapine—HTR1A—central nervous system—Parkinson's disease	0.000166	0.00157	CbGeAlD
Amoxapine—HTR7—nervous system—Parkinson's disease	0.000165	0.00156	CbGeAlD
Amoxapine—SLC6A2—central nervous system—Parkinson's disease	0.000164	0.00156	CbGeAlD
Amoxapine—DRD2—head—Parkinson's disease	0.000164	0.00156	CbGeAlD
Amoxapine—HTR1B—brain—Parkinson's disease	0.000163	0.00155	CbGeAlD
Amoxapine—GABRA1—brain—Parkinson's disease	0.000163	0.00155	CbGeAlD
Amoxapine—HTR1A—cerebellum—Parkinson's disease	0.000162	0.00154	CbGeAlD
Amoxapine—SLC6A3—brain—Parkinson's disease	0.000162	0.00154	CbGeAlD
Amoxapine—ADRA2A—medulla oblongata—Parkinson's disease	0.000161	0.00152	CbGeAlD
Amoxapine—HTR2A—cardiovascular system—Parkinson's disease	0.00016	0.00152	CbGeAlD
Amoxapine—ADRA1A—nervous system—Parkinson's disease	0.000159	0.00151	CbGeAlD
Amoxapine—HTR7—central nervous system—Parkinson's disease	0.000158	0.0015	CbGeAlD
Amoxapine—HTR2C—brain—Parkinson's disease	0.000156	0.00148	CbGeAlD
Amoxapine—DRD2—nervous system—Parkinson's disease	0.000156	0.00148	CbGeAlD
Amoxapine—HTR7—cerebellum—Parkinson's disease	0.000155	0.00147	CbGeAlD
Amoxapine—ADRA1A—central nervous system—Parkinson's disease	0.000153	0.00145	CbGeAlD
Amoxapine—Asenapine—CYP2D6—Parkinson's disease	0.000152	0.0254	CrCbGaD
Amoxapine—DRD2—central nervous system—Parkinson's disease	0.00015	0.00142	CbGeAlD
Amoxapine—ADRA1A—cerebellum—Parkinson's disease	0.000149	0.00142	CbGeAlD
Amoxapine—SLC6A4—brain—Parkinson's disease	0.000148	0.00141	CbGeAlD
Amoxapine—CHRM1—brain—Parkinson's disease	0.000148	0.0014	CbGeAlD
Amoxapine—HTR2B—brain—Parkinson's disease	0.000147	0.00139	CbGeAlD
Amoxapine—ADRA2A—midbrain—Parkinson's disease	0.000147	0.00139	CbGeAlD
Amoxapine—DRD2—cerebellum—Parkinson's disease	0.000146	0.00139	CbGeAlD
Amoxapine—ADRA2A—spinal cord—Parkinson's disease	0.000143	0.00136	CbGeAlD
Amoxapine—Olanzapine—HTR1A—Parkinson's disease	0.000141	0.0236	CrCbGaD
Amoxapine—HTR2A—medulla oblongata—Parkinson's disease	0.000137	0.0013	CbGeAlD
Amoxapine—HTR1A—brain—Parkinson's disease	0.000132	0.00125	CbGeAlD
Amoxapine—SLC6A2—brain—Parkinson's disease	0.000131	0.00124	CbGeAlD
Amoxapine—HRH1—head—Parkinson's disease	0.00013	0.00123	CbGeAlD
Amoxapine—ADRA2A—head—Parkinson's disease	0.000127	0.00121	CbGeAlD
Amoxapine—HTR7—brain—Parkinson's disease	0.000126	0.00119	CbGeAlD
Amoxapine—Zuclopenthixol—DRD2—Parkinson's disease	0.000126	0.021	CrCbGaD
Amoxapine—HTR2A—midbrain—Parkinson's disease	0.000125	0.00118	CbGeAlD
Amoxapine—HRH1—nervous system—Parkinson's disease	0.000123	0.00117	CbGeAlD
Amoxapine—HTR2A—spinal cord—Parkinson's disease	0.000122	0.00116	CbGeAlD
Amoxapine—ADRA1A—brain—Parkinson's disease	0.000121	0.00115	CbGeAlD
Amoxapine—ADRA2A—nervous system—Parkinson's disease	0.000121	0.00115	CbGeAlD
Amoxapine—Olanzapine—DRD2—Parkinson's disease	0.00012	0.02	CrCbGaD
Amoxapine—DRD2—brain—Parkinson's disease	0.000119	0.00113	CbGeAlD
Amoxapine—HRH1—central nervous system—Parkinson's disease	0.000118	0.00112	CbGeAlD
Amoxapine—ADRA2A—central nervous system—Parkinson's disease	0.000116	0.0011	CbGeAlD
Amoxapine—Loxapine—HTR7—Parkinson's disease	0.000114	0.0191	CrCbGaD
Amoxapine—ADRA2A—cerebellum—Parkinson's disease	0.000114	0.00108	CbGeAlD
Amoxapine—Quetiapine—HTR7—Parkinson's disease	0.000112	0.0187	CrCbGaD
Amoxapine—HTR2A—head—Parkinson's disease	0.000108	0.00103	CbGeAlD
Amoxapine—Loxapine—DRD3—Parkinson's disease	0.000108	0.018	CrCbGaD
Amoxapine—Loxapine—DRD1—Parkinson's disease	0.000106	0.0177	CrCbGaD
Amoxapine—Quetiapine—DRD3—Parkinson's disease	0.000105	0.0176	CrCbGaD
Amoxapine—Quetiapine—DRD1—Parkinson's disease	0.000103	0.0172	CrCbGaD
Amoxapine—HTR2A—nervous system—Parkinson's disease	0.000103	0.000974	CbGeAlD
Amoxapine—Loxapine—SLC6A3—Parkinson's disease	0.0001	0.0167	CrCbGaD
Amoxapine—HTR2A—central nervous system—Parkinson's disease	9.88e-05	0.000938	CbGeAlD
Amoxapine—CYP2D6—head—Parkinson's disease	9.86e-05	0.000936	CbGeAlD
Amoxapine—Zuclopenthixol—HTR2A—Parkinson's disease	9.71e-05	0.0163	CrCbGaD
Amoxapine—HTR2A—cerebellum—Parkinson's disease	9.66e-05	0.000916	CbGeAlD
Amoxapine—Clozapine—HTR7—Parkinson's disease	9.6e-05	0.0161	CrCbGaD
Amoxapine—HRH1—brain—Parkinson's disease	9.39e-05	0.000891	CbGeAlD
Amoxapine—CYP2D6—nervous system—Parkinson's disease	9.35e-05	0.000887	CbGeAlD
Amoxapine—Olanzapine—HTR2A—Parkinson's disease	9.25e-05	0.0155	CrCbGaD
Amoxapine—ADRA2A—brain—Parkinson's disease	9.23e-05	0.000875	CbGeAlD
Amoxapine—Chlordiazepoxide—CYP2D6—Parkinson's disease	9.04e-05	0.0151	CrCbGaD
Amoxapine—Clozapine—DRD3—Parkinson's disease	9.03e-05	0.0151	CrCbGaD
Amoxapine—CYP2D6—central nervous system—Parkinson's disease	9e-05	0.000854	CbGeAlD
Amoxapine—Zuclopenthixol—CYP2D6—Parkinson's disease	8.88e-05	0.0149	CrCbGaD
Amoxapine—Clozapine—DRD1—Parkinson's disease	8.86e-05	0.0148	CrCbGaD
Amoxapine—CYP2D6—cerebellum—Parkinson's disease	8.8e-05	0.000835	CbGeAlD
Amoxapine—Loxapine—HTR1A—Parkinson's disease	8.77e-05	0.0147	CrCbGaD
Amoxapine—Quetiapine—HTR1A—Parkinson's disease	8.56e-05	0.0143	CrCbGaD
Amoxapine—Olanzapine—CYP2D6—Parkinson's disease	8.46e-05	0.0142	CrCbGaD
Amoxapine—HTR2A—brain—Parkinson's disease	7.85e-05	0.000744	CbGeAlD
Amoxapine—Loxapine—DRD2—Parkinson's disease	7.44e-05	0.0124	CrCbGaD
Amoxapine—Clozapine—HTR1A—Parkinson's disease	7.36e-05	0.0123	CrCbGaD
Amoxapine—Quetiapine—DRD2—Parkinson's disease	7.26e-05	0.0121	CrCbGaD
Amoxapine—CYP2D6—brain—Parkinson's disease	7.15e-05	0.000678	CbGeAlD
Amoxapine—Clozapine—DRD2—Parkinson's disease	6.25e-05	0.0105	CrCbGaD
Amoxapine—Diazepam—CYP2E1—Parkinson's disease	6.09e-05	0.0102	CrCbGaD
Amoxapine—Olanzapine—ABCB1—Parkinson's disease	6.04e-05	0.0101	CrCbGaD
Amoxapine—Clozapine—CYP2E1—Parkinson's disease	6.01e-05	0.0101	CrCbGaD
Amoxapine—Loxapine—HTR2A—Parkinson's disease	5.75e-05	0.00962	CrCbGaD
Amoxapine—Quetiapine—HTR2A—Parkinson's disease	5.61e-05	0.00939	CrCbGaD
Amoxapine—Quetiapine—CYP2D6—Parkinson's disease	5.13e-05	0.00859	CrCbGaD
Amoxapine—Clozapine—HTR2A—Parkinson's disease	4.83e-05	0.00808	CrCbGaD
Amoxapine—Clozapine—CYP2D6—Parkinson's disease	4.41e-05	0.00739	CrCbGaD
Amoxapine—Quetiapine—ABCB1—Parkinson's disease	3.66e-05	0.00613	CrCbGaD
Amoxapine—Diazepam—ABCB1—Parkinson's disease	3.19e-05	0.00534	CrCbGaD
Amoxapine—Clozapine—ABCB1—Parkinson's disease	3.15e-05	0.00527	CrCbGaD
Amoxapine—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	6.42e-06	4.53e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IGF1R—Parkinson's disease	6.4e-06	4.51e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—FGB—Parkinson's disease	6.38e-06	4.5e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	6.36e-06	4.49e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	6.35e-06	4.48e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EDN1—Parkinson's disease	6.32e-06	4.46e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	6.32e-06	4.46e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	6.31e-06	4.45e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	6.28e-06	4.43e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—FGB—Parkinson's disease	6.28e-06	4.43e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	6.27e-06	4.43e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—FGB—Parkinson's disease	6.26e-06	4.42e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	6.25e-06	4.41e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	6.25e-06	4.41e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	6.24e-06	4.4e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—FGB—Parkinson's disease	6.24e-06	4.4e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	6.23e-06	4.4e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	6.23e-06	4.39e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	6.21e-06	4.38e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	6.15e-06	4.34e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	6.15e-06	4.34e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	6.14e-06	4.33e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	6.13e-06	4.33e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	6.13e-06	4.32e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	6.12e-06	4.31e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	6.11e-06	4.31e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	6.11e-06	4.31e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	6.11e-06	4.31e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	6.11e-06	4.31e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	6.08e-06	4.29e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	6.08e-06	4.29e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—NGF—Parkinson's disease	6.08e-06	4.29e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—NGF—Parkinson's disease	6.07e-06	4.28e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	6.04e-06	4.26e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	6.04e-06	4.26e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	6.03e-06	4.25e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	6.02e-06	4.25e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	6.02e-06	4.25e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	6e-06	4.23e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	6e-06	4.23e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IGF2—Parkinson's disease	5.96e-06	4.2e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	5.94e-06	4.19e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—NQO1—Parkinson's disease	5.93e-06	4.19e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	5.9e-06	4.17e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NGF—Parkinson's disease	5.9e-06	4.17e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IGF2—Parkinson's disease	5.88e-06	4.15e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—TH—Parkinson's disease	5.85e-06	4.13e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	5.84e-06	4.12e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	5.83e-06	4.11e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	5.81e-06	4.1e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NGF—Parkinson's disease	5.81e-06	4.1e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	5.81e-06	4.1e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HTR2A—Parkinson's disease	5.78e-06	4.08e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HTR2A—Parkinson's disease	5.78e-06	4.08e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	5.76e-06	4.06e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MAOB—Parkinson's disease	5.75e-06	4.06e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—CASP3—Parkinson's disease	5.75e-06	4.06e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	5.72e-06	4.03e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—IL6—Parkinson's disease	5.71e-06	4.03e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	5.71e-06	4.03e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	5.7e-06	4.02e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EDN1—Parkinson's disease	5.69e-06	4.02e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	5.68e-06	4.01e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	5.68e-06	4.01e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	5.62e-06	3.97e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EDN1—Parkinson's disease	5.62e-06	3.96e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CYCS—Parkinson's disease	5.61e-06	3.96e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	5.59e-06	3.95e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NGF—Parkinson's disease	5.55e-06	3.91e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	5.54e-06	3.91e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HTR2A—Parkinson's disease	5.53e-06	3.9e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	5.49e-06	3.87e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	5.45e-06	3.85e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	5.44e-06	3.84e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	5.42e-06	3.83e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—APOE—Parkinson's disease	5.38e-06	3.79e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—APOE—Parkinson's disease	5.37e-06	3.79e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	5.37e-06	3.79e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	5.34e-06	3.77e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	5.31e-06	3.75e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—MAPK8—Parkinson's disease	5.29e-06	3.73e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	5.28e-06	3.73e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	5.28e-06	3.73e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	5.28e-06	3.73e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	5.27e-06	3.72e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	5.27e-06	3.72e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	5.25e-06	3.71e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	5.25e-06	3.71e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NGF—Parkinson's disease	5.23e-06	3.69e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—APOE—Parkinson's disease	5.23e-06	3.69e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	5.17e-06	3.65e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	5.17e-06	3.65e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NGF—Parkinson's disease	5.16e-06	3.64e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—APOE—Parkinson's disease	5.14e-06	3.63e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	5.12e-06	3.61e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	5.1e-06	3.6e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	4.98e-06	3.51e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—COMT—Parkinson's disease	4.97e-06	3.51e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	4.96e-06	3.5e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	4.95e-06	3.49e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—GSTP1—Parkinson's disease	4.95e-06	3.49e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—MAOA—Parkinson's disease	4.94e-06	3.48e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	4.93e-06	3.48e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	4.91e-06	3.47e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—APOE—Parkinson's disease	4.91e-06	3.46e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	4.89e-06	3.45e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—HMOX1—Parkinson's disease	4.88e-06	3.44e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	4.87e-06	3.44e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	4.8e-06	3.39e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	4.8e-06	3.39e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ABCB1—Parkinson's disease	4.68e-06	3.3e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—APOE—Parkinson's disease	4.63e-06	3.27e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—INS—Parkinson's disease	4.59e-06	3.24e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—INS—Parkinson's disease	4.59e-06	3.24e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—APOE—Parkinson's disease	4.57e-06	3.22e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—GSTM1—Parkinson's disease	4.55e-06	3.21e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	4.5e-06	3.17e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NGF—Parkinson's disease	4.5e-06	3.17e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	4.47e-06	3.16e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—INS—Parkinson's disease	4.46e-06	3.15e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	4.43e-06	3.12e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	4.42e-06	3.12e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	4.4e-06	3.11e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—INS—Parkinson's disease	4.39e-06	3.1e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—GPX1—Parkinson's disease	4.35e-06	3.07e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	4.35e-06	3.07e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	4.33e-06	3.06e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	4.3e-06	3.03e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	4.28e-06	3.02e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	4.28e-06	3.02e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	4.27e-06	3.01e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	4.26e-06	3.01e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	4.26e-06	3e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	4.23e-06	2.98e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	4.22e-06	2.98e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	4.21e-06	2.97e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CTGF—Parkinson's disease	4.2e-06	2.96e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—INS—Parkinson's disease	4.19e-06	2.96e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	4.19e-06	2.96e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	4.14e-06	2.92e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	4.03e-06	2.84e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—MTHFR—Parkinson's disease	4.02e-06	2.84e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	3.98e-06	2.81e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	3.96e-06	2.79e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—INS—Parkinson's disease	3.95e-06	2.79e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NGF—Parkinson's disease	3.95e-06	2.79e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	3.91e-06	2.76e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—INS—Parkinson's disease	3.9e-06	2.75e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	3.89e-06	2.75e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	3.89e-06	2.74e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NGF—Parkinson's disease	3.88e-06	2.74e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NQO1—Parkinson's disease	3.87e-06	2.73e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	3.86e-06	2.73e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	3.85e-06	2.71e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—TH—Parkinson's disease	3.81e-06	2.69e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	3.8e-06	2.68e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	3.76e-06	2.65e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—APOE—Parkinson's disease	3.74e-06	2.64e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	3.69e-06	2.6e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	3.68e-06	2.6e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CYCS—Parkinson's disease	3.66e-06	2.58e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	3.62e-06	2.56e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	3.53e-06	2.49e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—APOE—Parkinson's disease	3.49e-06	2.47e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	3.44e-06	2.43e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—APOE—Parkinson's disease	3.43e-06	2.42e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	3.42e-06	2.41e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CASP3—Parkinson's disease	3.42e-06	2.41e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CASP3—Parkinson's disease	3.42e-06	2.41e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—INS—Parkinson's disease	3.4e-06	2.4e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL6—Parkinson's disease	3.4e-06	2.4e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL6—Parkinson's disease	3.39e-06	2.39e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—INS—Parkinson's disease	3.38e-06	2.39e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL6—Parkinson's disease	3.38e-06	2.38e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	3.37e-06	2.38e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	3.37e-06	2.37e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	3.32e-06	2.34e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	3.3e-06	2.33e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CASP3—Parkinson's disease	3.27e-06	2.31e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL6—Parkinson's disease	3.25e-06	2.29e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—COMT—Parkinson's disease	3.24e-06	2.29e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	3.22e-06	2.28e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MAOA—Parkinson's disease	3.22e-06	2.27e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—INS—Parkinson's disease	3.2e-06	2.26e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	3.18e-06	2.24e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	3.14e-06	2.22e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	3.14e-06	2.22e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	3.13e-06	2.21e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	3.12e-06	2.2e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	3.1e-06	2.19e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	3.05e-06	2.16e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	3.05e-06	2.15e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	3.01e-06	2.12e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—INS—Parkinson's disease	2.99e-06	2.11e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	2.96e-06	2.09e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CASP3—Parkinson's disease	2.94e-06	2.08e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—INS—Parkinson's disease	2.94e-06	2.07e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—INS—Parkinson's disease	2.93e-06	2.07e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—Parkinson's disease	2.93e-06	2.06e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—INS—Parkinson's disease	2.92e-06	2.06e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CASP3—Parkinson's disease	2.9e-06	2.05e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—Parkinson's disease	2.89e-06	2.04e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	2.88e-06	2.03e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	2.87e-06	2.02e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GPX1—Parkinson's disease	2.84e-06	2e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	2.71e-06	1.91e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—INS—Parkinson's disease	2.67e-06	1.89e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	2.67e-06	1.88e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	2.62e-06	1.85e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	2.53e-06	1.79e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	2.52e-06	1.78e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	2.52e-06	1.77e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	2.5e-06	1.77e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—Parkinson's disease	2.44e-06	1.72e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	2.33e-06	1.64e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	2.31e-06	1.63e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.22e-06	1.57e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.21e-06	1.56e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.19e-06	1.54e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	2.18e-06	1.54e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	2.18e-06	1.53e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.17e-06	1.53e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	2.17e-06	1.53e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	2.16e-06	1.52e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	2.14e-06	1.51e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	2.13e-06	1.5e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—INS—Parkinson's disease	2.08e-06	1.47e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.04e-06	1.44e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.01e-06	1.42e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—Parkinson's disease	2.01e-06	1.42e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	2.01e-06	1.42e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—Parkinson's disease	2.01e-06	1.41e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	2e-06	1.41e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	1.99e-06	1.4e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	1.98e-06	1.39e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	1.97e-06	1.39e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—Parkinson's disease	1.95e-06	1.38e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—Parkinson's disease	1.92e-06	1.35e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—Parkinson's disease	1.83e-06	1.29e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.83e-06	1.29e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—Parkinson's disease	1.73e-06	1.22e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—Parkinson's disease	1.7e-06	1.2e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.49e-06	1.05e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.48e-06	1.04e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.3e-06	9.2e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.28e-06	9.06e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.28e-06	9.04e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	1.28e-06	9.01e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.26e-06	8.87e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.17e-06	8.24e-06	CbGpPWpGaD
